Moberg Pharma AB (publ) Cash Flow-to-Debt Ratio
Moberg Pharma AB (publ) cash flow-to-debt ratio. Moberg Pharma AB (publ) (MOB) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of Skr1.52 Million could theoretically repay 0% of its total liabilities (Skr17.04 Million) in one year. Check cash flow quality index of Moberg Pharma AB (publ) to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Moberg Pharma AB (publ) (2008–2025)
Cash flow-to-debt ratio of Moberg Pharma AB (publ) from 2008 to 2025. Historical debt coverage capacity for Moberg Pharma AB (publ) across 18 annual periods. Check MOB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Moberg Pharma AB (publ) Cash Flow-to-Debt Ratio by Year (2008–2025)
Moberg Pharma AB (publ) cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Moberg Pharma AB (publ). For the full cash flow conversion analysis, see MOB cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.03x | Skr-17.49 Million | Skr17.04 Million | ▼ -20.0% |
| 2024 | -0.85x | Skr-16.47 Million | Skr19.27 Million | ▲ +38.2% |
| 2023 | -1.38x | Skr-33.20 Million | Skr24.01 Million | ▼ -153.3% |
| 2022 | -0.55x | Skr-16.84 Million | Skr30.84 Million | ▲ +39.9% |
| 2021 | -0.91x | Skr-15.30 Million | Skr16.84 Million | ▼ -158.0% |
| 2020 | -0.35x | Skr-29.93 Million | Skr85.00 Million | ▼ -321.9% |
| 2019 | 0.16x | Skr3.95 Million | Skr24.91 Million | ▲ +41.2% |
| 2018 | 0.11x | Skr73.89 Million | Skr657.60 Million | ▲ +40.1% |
| 2017 | 0.08x | Skr53.82 Million | Skr670.85 Million | ▲ +399.8% |
| 2016 | -0.03x | Skr-17.94 Million | Skr670.55 Million | ▼ -103.9% |
| 2015 | 0.69x | Skr30.72 Million | Skr44.63 Million | ▲ +138.4% |
| 2014 | 0.29x | Skr16.16 Million | Skr55.97 Million | ▲ +742.7% |
| 2013 | -0.04x | Skr-3.15 Million | Skr70.11 Million | ▼ -148.6% |
| 2012 | 0.09x | Skr9.48 Million | Skr102.53 Million | ▲ +116.1% |
| 2011 | -0.58x | Skr-9.02 Million | Skr15.67 Million | ▲ +77.9% |
| 2010 | -2.60x | Skr-30.41 Million | Skr11.69 Million | ▲ +47.6% |
| 2009 | -4.96x | Skr-25.26 Million | Skr5.09 Million | ▼ -4.7% |
| 2008 | -4.74x | Skr-34.89 Million | Skr7.36 Million | — |